Histodine
Histodine
Authorised
- Chlorphenamine maleate
Product identification
Medicine name:
Histodine
Histodine 10 mg/ml Oplossing voor injectie
Histodine 10 mg/ml Solution injectable
Histodine 10 mg/ml Injektionslösung
Active substance:
- Chlorphenamine maleate
Target species:
-
Cattle
Route of administration:
-
Intramuscular use
-
Intravenous use
Product details
Active substance and strength:
-
Chlorphenamine maleate10.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Cattle
-
Milk12hour
-
Meat and offal1day
-
-
-
Intravenous use
-
Cattle
-
Milk12hour
-
Meat and offal1day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QR06AB04
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Package description:
- 250 ml polypropylene vial, closed with a coated bromobutyl rubber stopper and aluminium cap in a carton box
- 100 ml polypropylene vial, closed with a coated bromobutyl rubber stopper and aluminium cap in a carton box
- 250 ml clear Type II glass vial, closed with a coated bromobutyl rubber stopper and aluminium cap in a carton box
- 100 ml clear Type II glass vial, closed with a coated bromobutyl rubber stopper and aluminium cap in a carton box
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Dechra Regulatory B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Produlab Pharma B.V.
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
Reference member state:
-
Netherlands
Procedure number:
- NL/V/0211/001
Concerned member states:
-
Belgium
-
Cyprus
-
Czechia
-
Estonia
-
France
-
Hungary
-
Iceland
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Luxembourg
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
English (PDF)
Download Published on: 23/05/2022
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.